Health
New CRISPR system edits body’s response to prevent immunity against AAVs – Drug Target Review
A CRISPR system that suppresses AAV antibody production has been developed to prevent immunity against the gene therapy.
Posted: 4 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
A novel CRISPR system that suppresses genes related to adeno-associated virus (AAV) antibody production has been developed to prevent immunity against the gene therapy.
Researchers have created a new CRISPR system that suppresses genes related to adeno-associated virus (AAV) antibody production so that the virus can deliver its cargo unimpeded.
According to the researchers from the University of Pittsburgh School…
-
General19 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News18 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General16 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
General24 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says